Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and Safety of Sacubitril/Valsartan Versus Amlodipine in Japanese Patients With Essential Hypertension: A Randomized, Multicenter, Open-Label, Noninferiority Study (PARASOL Study).
Yamamoto K, Yarimizu D, Shimanishi A, Eguchi S, Iekushi K, Takami Y, Nozato Y, Kario K, Rakugi H. Yamamoto K, et al. Among authors: yarimizu d. J Clin Hypertens (Greenwich). 2024 Dec 4. doi: 10.1111/jch.14938. Online ahead of print. J Clin Hypertens (Greenwich). 2024. PMID: 39632589 Free article.
Impact of Implementation of a Region-Wide Low-Density Lipoprotein Cholesterol Management Clinical Pathway for the Secondary Prevention of Acute Myocardial Infarction.
Kurobe M, Baba K, Nunohiro T, Ishizaki M, Furudono S, Nakata T, Koide Y, Hazama M, Sakai K, Muto S, Yamaguchi T, Fujii T, Yarimizu D, Toda M, Iekushi K, Ikeda S, Maemura K. Kurobe M, et al. Among authors: yarimizu d. Circ J. 2024 Oct 25;88(11):1825-1832. doi: 10.1253/circj.CJ-24-0338. Epub 2024 Sep 14. Circ J. 2024. PMID: 39284715 Free article.
Twenty-Four-Hour Blood Pressure-Lowering Efficacy of Sacubitril/Valsartan Versus Olmesartan in Japanese Patients With Essential Hypertension Based on Nocturnal Blood Pressure Dipping Status: A Post Hoc Analysis of Data From a Randomized, Double-Blind Multicenter Study.
Kario K, Rakugi H, Yarimizu D, Morita Y, Eguchi S, Iekushi K. Kario K, et al. Among authors: yarimizu d. J Am Heart Assoc. 2023 Apr 18;12(8):e027612. doi: 10.1161/JAHA.122.027612. Epub 2023 Apr 7. J Am Heart Assoc. 2023. PMID: 37026551 Free PMC article. Clinical Trial.
Intracrine activity involving NAD-dependent circadian steroidogenic activity governs age-associated meibomian gland dysfunction.
Sasaki L, Hamada Y, Yarimizu D, Suzuki T, Nakamura H, Shimada A, Pham KTN, Shao X, Yamamura K, Inatomi T, Morinaga H, Nishimura EK, Kudo F, Manabe I, Haraguchi S, Sugiura Y, Suematsu M, Kinoshita S, Machida M, Nakajima T, Kiyonari H, Okamura H, Yamaguchi Y, Miyake T, Doi M. Sasaki L, et al. Among authors: yarimizu d. Nat Aging. 2022 Feb;2(2):105-114. doi: 10.1038/s43587-021-00167-8. Epub 2022 Feb 10. Nat Aging. 2022. PMID: 37117756 Free PMC article.
Angiotensin II triggers expression of the adrenal gland zona glomerulosa-specific 3β-hydroxysteroid dehydrogenase isoenzyme through de novo protein synthesis of the orphan nuclear receptors NGFIB and NURR1.
Ota T, Doi M, Yamazaki F, Yarimizu D, Okada K, Murai I, Hayashi H, Kunisue S, Nakagawa Y, Okamura H. Ota T, et al. Among authors: yarimizu d. Mol Cell Biol. 2014 Oct;34(20):3880-94. doi: 10.1128/MCB.00852-14. Epub 2014 Aug 4. Mol Cell Biol. 2014. PMID: 25092869 Free PMC article.